FDA approves UroGen’s bladder cancer hydrogel after negative adcomm votenews2025-06-12T17:42:23+00:00June 12th, 2025|Endpoints News|
Two new ACIP picks were paid experts against Merck in courtnews2025-06-12T16:19:00+00:00June 12th, 2025|Endpoints News|
Trump officials seek price details as they assess most favored nation plannews2025-06-11T20:00:08+00:00June 11th, 2025|Endpoints News|
HHS urges against reviving Chamber of Commerce’s IRA suitnews2025-06-11T19:57:30+00:00June 11th, 2025|Endpoints News|
Federal officials plan listening sessions to address drug competitionnews2025-06-11T19:39:57+00:00June 11th, 2025|Endpoints News|
Nuvation Bio scores first FDA approval for new lung cancer drugnews2025-06-11T17:56:46+00:00June 11th, 2025|Endpoints News|
Reality check: Unpacking the $150B GLP-1 market forecastsnews2025-06-11T14:00:23+00:00June 11th, 2025|Endpoints News|
Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in Marchnews2025-06-11T01:06:41+00:00June 11th, 2025|Endpoints News|
Argenx says its drug Vyvgart looks promising in two more autoimmune diseasesnews2025-06-11T00:57:18+00:00June 11th, 2025|Endpoints News|
